How do you manage patients who are Hepatitis B core antibody positive/surface antigen negative and starting a biologic DMARD (other than rituximab)?

Topics: Rheumatology • Rheumatoid Arthritis • Hepatitis B • bDMARD • General Rheumatology • Infectious Disease

Answer from: at Academic Institution

According to the 2015 American College of Rheumatology Guidelines, a patient with natural immunity to Hepatitis B (Core & Surface Antibody-positive; Antigen-negative, normal liver function tests) can be treated as any other patient. However, monitoring of viral load is recommended "regularly" at...

Comments

at Cleveland Clinic
We rely heavily on the AASLD guidelines which are ...

at The University of Tennessee Health Science Center/West Cancer Center
AGA 2015 Guidelines are somewhat different from AA...

Related Questions